ArticleMolecular cancer therapeutics2026

Targeting O6-methylguanine-DNA Methyltransferase Deficiency in Preclinical Models of Extracranial Human Cancers with a Tumor-Selective DNA-Modifying Agent.

Ranjini K Sundaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.